D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.

4576 | T

Overview

Corporate Details

ISIN(s):
JP3548740004
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D.Western Therapeutics Institute, Inc. is a university-originated biotechnology venture focused on drug discovery and development. The company aims to create innovative and more effective drugs for patients worldwide by leveraging its core technology, which includes a proprietary compound library and specialized expertise in inhibitors, particularly protein kinases. Its business model centers on discovering and developing novel drug candidates before out-licensing them to larger pharmaceutical companies for late-stage clinical trials and commercialization. The company's development pipeline includes therapeutic drugs for various conditions, with a known focus in areas such as ophthalmology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:45
Interim Report
半期報告書-第28期(2025/01/01-2025/12/31)
Japanese 175.2 KB
2025-08-14 08:45
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-07-15 08:30
Registration Form
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Post-Annual General Meeting Information
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Registration Form
確認書
Japanese 8.2 KB
2025-03-25 07:30
Governance Information
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Major Shareholding Notification
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Regulatory News Service
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Registration Form
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for D.Western Therapeutics Institute, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.